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Introduction
In 1987, Dr. James Cox introduced the ﬁrst
eﬀective surgical treatment for atrial ﬁbrillation
(AF) at Barnes-Jewish Hospital in St. Louis,
USA.1–3) The operation was termed the Maze
procedure, and involved a relatively complicated
set of incisions on both the right and left atria. It
was designed to block the multiple macroreentrant
circuits felt to be responsible for AF. The ﬁnal
iteration of this procedure was termed the Cox-Maze
III. This operation was extremely eﬀective at curing
AF. In a large series from our institution reported
in 2003, the freedom from recurrent AF was 97%
at 10 years in those patients undergoing the Maze
procedure concomitant with another cardiac opera-
tion and 92% in stand-alone Maze group at 14
years.4) (Figure 1) This high success rate has been
replicated by a number of other groups around the
world.5–7) Unfortunately, few surgeons adopted the
Maze procedure. It was a lengthy and diﬃcult
procedure which required cardiopulmonary bypass
and an arrested heart. At our center, the mean cross-
clamp time required to perform a lone Cox-Maze III
procedure was 93 34 minutes.4) The procedure
also had signiﬁcant morbidity, with relatively long
lengths of hospital stay.
Ablation Technology for AF
The shortcomings of the Cox-Maze III procedure
spurred interest in developing less-invasive surgical
approaches to AF. The principal strategy of groups
around the world has been to replace the surgical
incisions with linear lines of ablation using a variety
of diﬀerent energy sources.8–11) Cryosurgery, radio-
frequency energy, microwave, laser, and high-
frequency ultrasound all have been used, both
experimentally and clinically, for the surgical treat-
ment of AF.12–20) The various technologies can be
organized into two major groups: those that use a
unipolar energy source and those that use a bipolar
clamp.
The unipolar energy sources (cryosurgery, unipo-
lar radiofrequency energy, microwave, laser, ultra-
sound) radiate either heat or cold from a single
source. With the exception of high-frequency ultra-
sound and laser, the energy is unfocused. The only
indications of when the ablation results in a trans-
mural lesion are visual cues (i.e., blanching of the
myocardium, ice-ball). Since most of these devices
were released clinically without accurate dose-
response studies, there have been occasional instan-
ces of collateral cardiac and extra-cardiac dam-
age.21–23) Moreover, unipolar energy sources have
had diﬃculty creating transmural lesions when used
from the epicardial surface on the beating heart.24–27)
This is because of the heat sink eﬀect of the
circulating intracavitary blood pool. For instance,
with microwave energy, our laboratory has shown a
direct relationship between the depth of lesion
penetration and the degree of intracavitary blood
ﬂow.28) While ultrasound and laser can result in a
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focused delivery of energy, these energy sources
have a relatively ﬁxed depth of penetration. This can
be a problem because of the variability of atrial wall
thickness in normal and pathological states.
Bipolar radiofrequency ablation has been able to
overcome some of these shortcomings.29–32) Since
energy is delivered between two closely approx-
imately electrodes embedded in a jaw of a clamp, the
energy is focused and results in discrete lesions. The
energy is conﬁned to within the jaws of the clamp,
decreasing the possibility of collateral cardiac or
extra-cardiac damage. By measuring the tissue
conductance between the two electrodes, algorithms
have been developed which experimentally have
predicted lesion transmurality.29,31) Finally, bipolar
ablation has the advantage of shorter ablation times
when compared to unipolar devices. The major
weakness of these devices is they can only ablate
tissue that can be clamped within the jaws of the
device. This has limited the potential lesion sets,
particularly on the beating heart. In clinical practice,
these devices have been incapable of fully ablating
the right and left atrial isthmuses, and have required
adjunctive unipolar ablation to perform a complete
Cox-Maze lesion set.
The ability of these new technologies to replace
the incisions of the cut-and-sew Cox-Maze proce-
dure without sacriﬁcing procedural eﬃcacy has
recently been demonstrated.15,16,33) Our group has
used bipolar radiofrequency ablation to replace most
of the lesions of the cut-and-sew Cox Maze III pro-
cedure.20,33,34) This new operation has been termed
the Cox-Maze IV, and preserves virtually the entire
lesion set.35) (Figures 2 and 3) Between June, 2002
and June, 2006, this procedure was performed on
141 consecutive patients in St. Louis. The average
age of these patients was 61 12 years. Sixty-one
percent were men and 39% were women. The
average preoperative duration of AF was 6:6 7:2
years with a mean left atrial diameter of 5:7 1:3
cm. In this study cohort, 63% of patients had
paroxysmal AF, while the rest had either permanent
or persistent AF. Fifty of the patients underwent a
100
80
60
40
20
0
0 2 4 6 8 10
TIME (YEARS)
%
 
FR
EE
 F
R
O
M
 A
F
86 64
112 80
60
65
38
46
13
21
6
11
C
L
Figure 1 Freedom from Recurrent AF.
Kaplan-Meier survival analysis of freedom from recurrent AF.
The numbers on each line indicate the number of patients at risk.
There was no diﬀerence in the long-term estimate of freedom from
AF between the stand-alone maze group (L) and the concomitant
group (C; P = .64).
(Reprinted form ‘‘Prasad SM, et al: J Thorac Cardiovasc Surg
2003; 126(6): 1822–1827’’ with permission from American
Association for Thoracic Surgery.)
Figure 2 Right atrial lesion set.
Illustration of right atrial lesion set.
White lines indicate radiofrequency
ablation. Cryoablation is used to com-
plete the ablation line on the tricuspid
valve annulus.
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stand-alone Cox-Maze procedure. Of the concom-
itant group, the majority of patients underwent the
Maze procedure with mitral and/or tricuspid valve
surgery (n = 48). Twenty-seven patients had the
procedure with coronary bypass grafting, with or
without the valve procedures. Successful intraoper-
ative pulmonary vein isolation was documented by
pacing in every patient (139 of 139) who could be
cardioverted into sinus rhythm.
With this ablation-assisted procedure, the mean
cross-clamp time for a lone Cox-Maze IV procedure
was signiﬁcantly less than our historical experience
with the Cox-Maze III (35 15 minutes versus 93
34 minutes, p < 0.001). Our overall operative mor-
tality was 2.9% with no operative deaths in stand-
alone Cox-Maze IV group. At a mean followup of
12 11 months, 92% of patients were free from AF
at a year. Freedom from both AF and antiarrhythmic
drugs at one year was 81%.
In order to see if these results were comparable
to our prior experience with the Cox-Maze III, a
propensity analysis was performed.36) A logistic
regression analysis identiﬁed co-variates among
seven baseline variables including gender, age, pre-
operative left ventricular ejection fraction, NYHA
congestive heart failure classiﬁcation, type of AF,
duration of AF and type of operative procedure
performed. Fifty-eight patients who underwent a
Cox-Maze IV were matched with a similar number
of patients having a Cox-Maze III based on a
propensity score. There was no signiﬁcant diﬀerence
in the freedom from AF at 3, 6 or 12 months between
the two groups. Thus, our early experience has
suggested that bipolar radiofrequency ablation can
be used to replace the surgical incisions and simplify
the Cox-Maze procedure. While a number of pro-
cedures have been performed through a right mini-
thoracotomy, this operation still requires cardiopul-
monary bypass.
A number of other groups throughout the world
also have reported excellent results with an ablation-
assisted Cox-Maze procedure.15,16,33) However, a
once staid ﬁeld has been thrown into controversy
by the introduction of a myriad of new operations for
AF. These have included pulmonary vein isola-
tion,37,38) an ever-growing number of diﬀerent left
atrial lesion patterns, and biatrial variants of the
Cox-Maze procedure.39–45) The confusion has been
further compounded by the introduction of new
ablation technologies, most of which have been
inadequately investigated prior to their clinical
debuts. At the present time, it remains unclear what
should be the appropriate lesion set or the preferred
ablation technology. What has been shown deﬁnitely
is that some patients are cured by less extensive
operations than the full Cox-Maze lesion set. A
recent report has described a high success rate for
pulmonary vein isolation in patients with paroxysmal
lone AF.46) On the other side, there are patients who
are not cured even by a complete Cox-Maze pro-
cedure, particularly those with large left atria.47) In
the next section, we will speculate on a rational way
forward out of the present quagmire.
Future Directions in Atrial Fibrillation Sur-
gery
Looking into the future, our principal goal should
be to develop a minimally invasive procedure that
is simple and applicable to all patients with AF.
Ideally, this operation should be able to be per-
formed with minimal access and without the use of
cardiopulmonary bypass. The operation would pre-
serve normal atrial physiology and have minimal
to no morbidity. In order to be competitive with
catheter ablation for the treatment of lone AF, this
operation will have to have excellent long-term cure
rates (likely above 90%). To achieve this goal,
signiﬁcant progress will need to be made in four
major areas:
1. Development of better ablation technologies.
2. Understanding the mechanism of AF in each
individual patient.
3. Redesigning our surgery based on these mech-
anisms and a better understanding of the elec-
trophysiological eﬀect of surgical ablation.
Figure 3 Left atrial lesion set.
Illustration of left atrial lesion set. White lines indicate radio-
frequency ablation. Cryoablation is used to complete the ablation
line on the mitral valve annulus.
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4. Deﬁning the eﬀect of ablation lesions on atrial
hemodynamics and function.
An Ideal Ablation Technology
The perfect ablation technology for patients with
lone AF would be able to create transmural linear
lesions in the beating heart and allow for a thoraco-
scopic approach to minimize operative trauma. In
order to achieve high success rates, this technology
not only may need to replicate many of the lesions of
the Cox-Maze procedure, but also be able to create
new ones. This would require a unipolar energy
source for at least some of the right and left atrial
ablation lines. While there are interesting candidates
in development, no technology has yet achieved this
goal.
While bipolar radiofrequency ablation has its
advantages, it also has signiﬁcant shortcomings.
The clamps are bulky and diﬃcult to use through
fully endoscopic approaches. Moreover, on the
beating heart, these devices are only able to perform
pulmonary vein isolation. Evidence is accumulating
that pulmonary vein isolation is an inadequate
operation for many patients with AF in the setting
of organic heart disease and for patients with
permanent lone AF. Moreover, for the prevention
of late atrial ﬂutter, it is mandatory to create right
and left atrial isthmus lesions.
An ideal ablation technology will need to be able
to reliably perform transmural lesions on varying
thicknesses of atria. Moreover, they will have to
have clearly deﬁned dose-response curves in order to
avoid collateral injury to cardiac and extra-cardiac
structures. This represents a challenge both to in-
dustry and to academic cardiothoracic surgeons.
Understanding the Mechanisms of Atrial Fi-
brillation
Since it was not possible by mapping to deﬁne the
mechanism of AF prior to surgery, the Cox-Maze
procedure was designed to stop all possible macro-
reentrant circuits that were felt to be responsible
for AF. The precise lesion set of the Cox-Maze
procedure was derived empirically, and the partic-
ular importance of each incision/ablation has not
been deﬁned experimentally. Unfortunately, the
underlying theory on which the procedure was based
has been shown to be wrong in many patients. It is
now known that there are multiple diﬀerent possible
mechanisms responsible for AF, including focal
triggers, and single and multiple rotors.3,48–50) A
directed and potentially less-invasive operation
could be developed if it became possible to elucidate
the mechanisms of AF in each patient prior to the
curative interventional procedure. Unfortunately,
this has not been possible with the present technol-
ogy. AF is a complex arrhythmia, and has been
diﬃcult to deﬁne even with multipoint epicardial
mapping. The mapping systems available for non-
invasive endocardial mapping have relatively poor
resolution. While electrophysiologists have been
able to map high-frequency activation of the pulmo-
nary veins as well as complex fractionated electro-
grams and have been successful in directing therapy
to these areas, the mapping of AF has required
sophisticated epicardial activation sequence map-
ping.51) Unfortunately, this is both invasive and time-
consuming. Epicardial mapping can be performed in
the operating room, but requires a large incision,
usually a median sternotomy, in order to place the
epicardial plaques.3,50) The analysis of the activation
times is lengthy, and has not allowed for real-time
analysis, except in rare instances. In order to
overcome these shortcomings, our group and others
have developed frequency mapping.52,53) This type
of mapping simply identiﬁes the fastest activating
regions during AF, by using short-time fast Fourier
transformation to determine the frequency of acti-
vation of each electrode.52) The advantage of this
type of mapping is that it requires very little
subjective analysis and can be done in real time.
Our group has recently performed a study in which
frequency mapping was performed in 12 patients
with paroxysmal and 11 patients with permanent
AF.52) The duration of AF in each patient was over 6
months, with an average duration of over 8 years.
Isofrequency mapping demonstrated that 91% of
the patients exhibited a distinct region of maximum
(dominant) frequency at least once during the re-
cording period. A distinct region of stable dominant
frequency was located in the left atrium 30% of the
time and the right atrium 12% of the time for the
entire recording period. The location of dominant
frequency changed during the recording period in
48% of the patients. It remains to be proven whether
targeting these areas of fastest activation will suc-
cessfully cure AF in patients.
The work from our laboratory regarding the
complexity of AF in patients and the heterogeneity
of diﬀerent mechanisms and site of origin have been
supported by other groups.48–50) In the electrophysi-
ology laboratory, triggers for paroxysmal AF can
arise from substrates in both the right and left atria,
although they most commonly originate from the
pulmonary veins.54,55)
The complexity of AF and the variety of mech-
Damiano RJ Future directions in atrial ﬁbrillation surgery
15
anisms testify to the need for more reliable diagnoses
preoperatively. One area with signiﬁcant promise is
ECG imaging (ECGI).56–61) This new technique
involves recording body surface electrograms from
250 sites. An inverse solution can be calculated
using anatomic information obtained by a CT scan
made at the time of the recording. Electrograms can
be reconstructed on the atrial epicardial surface. This
technique has been shown to work well for normal
sinus rhythm and atrial ﬂutter. Working with the
developer of ECGI, Dr. Yoram Rudy of the Depart-
ment of Biomedical Engineering at Washington
University, data were recorded from patients with
permanent AF. Activation sequence and frequency
maps were created for each patient. Because data can
be recorded non-invasively, recordings can be made
over longer periods of time. In addition, unlike
intraoperative mapping, the patient is not anesthe-
tized and the chest is intact. Our preliminary studies
show both focal and reentrant sources of AF. The
location of the sources changed over time in all
the patients. These data may allow us to deﬁne the
underlying activation patterns noninvasively prior
to surgery and could be used to design surgical
strategies speciﬁc to the individual patient.
Understanding the Eﬀect of Ablation on Atrial
Electrophysiology
Another area for progress is in the better under-
standing of the eﬀect of linear ablation lines on the
electrophysiology of AF. In other words, if the
mechanisms of arrhythmia cannot be deﬁned, can
ablation lines be placed in a pattern that will make
the atria unable to ﬁbrillate? The Cox-Maze III and
IV procedures clearly do not achieve this goal. In
fact, in large left atria, the Cox-Maze procedure has
had poor results.47) In order to deﬁne the relationship
between tissue geometry in AF, a study was per-
formed in our laboratory to determine the association
between the probability of maintaining AF and the
width, area, weight, eﬀective refractory period and
conduction velocity of the atrial tissue.62)
Using an isolated perfused canine atria prepara-
tion, a recording plaque containing 250 unipolar
electrograms was used to determine atrial activation
and refractory periods. Eﬀective refractory periods
(ERPs) were shortened with the administration of
acetylcholine. AF was initiated in the entire atria
ﬁrst. Any section of tissue that maintained AF was
divided until the arrhythmia was no longer indu-
cible. ERPs and conduction velocities were meas-
ured in all of the sections after each ablation, and the
wavelengths were calculated. The probability of AF
was found to be correlated with increasing tissue
areas, widths and weights (p < 0.001) (Figure 4).
With shorter ERPs and shorter wavelengths, there
was an increased probability of sustained AF. This
data then were interpolated to the normal range
of eﬀective refractory periods seen in humans
(Figure 5). These data may help to design more
eﬀective interventional procedures in the future. It
may allow surgeons to design custom operations for
each patient based on the mechanism of their
arrhythmia and their speciﬁc atrial geometry and
electrophysiology.
The Eﬀect of Ablation on Atrial Function
Another challenge in the future is to create
operations that have minimal impact on atrial
function. There has been evidence that the full
Cox-Maze lesion set has a signiﬁcant detrimental
eﬀect on right and left atrial function. In a study
published from our institution, only 61% of patients
had left atrial contraction after the Maze procedure.
Right atrial contraction was present in 83% of
patients.63) The extensive lesions of the Cox-Maze
procedure also have been shown by others to impair
atrial function.64–73) Unfortunately, echocardiogra-
phy does not have the resolution to deﬁne the precise
degree of left atrial dysfunction, and is best at
determining only whether it is present or not. While
there is excellent imaging technology with higher
resolution (gated MRI, CT scan), there has been no
available software to oﬀer analysis of atrial function.
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Figure 4 Probability of AF vs. Area vs. ERP.
Logistical regression presenting probability of sustained AF on the
Y-axis, area (mm2) on the X-axis, and ERPs (10, 40, 70, and
100ms) plotted on the graph. With increasing areas and decreas-
ing ERPs, there is an increased probability of sustained AF.
(Reprinted form ‘‘Prasad SM, et al: J Thorac Cardiovasc Surg
2003; 126(6): 1822–1827’’ with permission from American
Association for Thoracic Surgery.)
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Recently, our laboratory has utilized cardiac MRI
to non-invasively characterize left atrial function by
assessing atrial volumes and wall motion. In twenty
healthy subjects, global left atrial function was
characterized by analyzing its reservoir, conduit,
and booster pump functions from the instantaneous
left atrial volume vs. cardiac cycle curves. The
percent contribution to left ventricular stroke volume
(LVSV) by the left atrial booster pump volume was
22 5%, by the reservoir volume 39 12%, and by
the conduit volume 40 12%. Regional left atrial
function was also characterized in this study by
quantifying left atrial segmental wall motion during
the cardiac cycle. The anterior left atrial wall
shortened by 26 7%, posterior wall by 27 8%,
medial wall by 30 9%, and lateral wall by 29
10%. Our laboratory is currently investigating the
eﬀects of the Cox-Maze IV procedure on global and
regional left atrial function. So far, three patients
who underwent a lone Cox-Maze IV procedure for
paroxysmal AF have undergone preoperative and 30-
day postoperative MRI to assess the changes in left
atrial function. Comparing the preoperative and
postoperative data, there was a decrease in the mean
percent contribution of the left atrial booster pump
volume (16 14% vs. 7 5%) and reservoir vol-
ume (28 3 vs. 24 4%) to LVSV, and an increase
in the mean percent left atrial conduit volume
contribution (56 15% vs. 69 9%) to LVSV.
Furthermore, there was a signiﬁcant decrease in
the mean left atrial anterior, posterior, medial, and
lateral wall percent shortening compared to the
preoperative values. These early results have shown
that there is a signiﬁcant impairment of atrial
function and wall motion following the Cox-Maze
procedure. Further studies are needed to determine
the eﬀect of each of the ablation lines on atrial
function. This will allow for the development of
more physiologic procedures in the future.
Conclusions
This is a time of great excitement in the ﬁeld of
surgery for AF. The introduction of new ablation
technology and novel surgical approaches have
revolutionalized our thinking and greatly increased
the adoption of AF surgery in the wider surgical
community. There also has been a startling transition
from a time when there was only one eﬀective
procedure, the Cox-Maze III, to the present confus-
ing melange of approaches and technology. For
the ﬁeld to progress, surgeons must become more
electrophysiologically sophisticated. There needs to
be a better understanding on the mechanisms of AF
in the individual patient. At the same time, it is
imperative to better deﬁne the complex interplay
between our ablation lines and atrial electrophysiol-
ogy and function. Over the coming years, it is likely
that this new knowledge will further transform AF
surgery. It is our prediction and hope that a better
understanding of AF will lead us back to the original
paradigm of arrhythmia surgery. In the early days of
arrhythmia surgery (i.e., Wolﬀ-Parkinson-White and
ventricular tachycardia), operations were based on a
precise understanding of the mechanism and ana-
tomical substrate responsible for the arrhythmia.
With advances in ECGI, mapping, cardiac MRI and
CT, the mechanisms and substrate of AF may be able
to be delineated in the individual patient prior to
surgery. An operation then could be tailored to each
individual patient with assured high success rates.
This would then allow for the rational development
of eﬀective minimally invasive procedures and new
ablation technologies. Responsible innovation, care-
ful experimental and clinical research, and close
collaboration with our electrophysiological collea-
gues and industry, will guide us into this exciting
new era of AF surgery.
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